FOXO1 and type 2 diabetes mellitus: Besides, MNAM also improves hepatic insulin sensitivity of mice with type 2 diabetes via activation of SIRT1 and inhibition of forkhead box O1 (FOXO1) acetylation (Zhang et al. 2020).